Stocks of Oscar Health Inc (NYSE:OSCR) traded higher last session on Wall Street, down -7.46% to $13.89.
OSCR stock price is now 0.81% away from the 50-day moving average and -12.37% away from the 200-day moving average. The market capitalization of the company currently stands at $3.54B.
With the price target reduced from $20 to $16, Wells Fargo Downgraded its rating from Overweight to Equal Weight for Oscar Health Inc (NYSE: OSCR). On December 10, 2024, Jefferies recently initiated its ‘Underperform’ rating on the stock quoting a target price of $12, while ‘BofA Securities’ rates the stock as ‘Underperform’
In other news, ALESSANDREA QUANE, Former Officer bought 148,280 shares of the company’s stock on May 16 ’25. The stock was bought for $2,598,488 at an average price of $17.52. An SEC document containing details of the transaction can be found on the SEC’s website. On May 12 ’25, Director Robinson Elbert O. Jr. sold 25,000 shares of the business’s stock. A total of $410,750 was realized by selling the stock at an average price of $16.43. This leaves the insider owning 64,512 shares of the company worth $0.9 million. A total of 28.95% of the company’s stock is owned by insiders.
The net profit margin was 1.22% and return on equity was 10.43% for OSCR. The company reported revenue of $3.05 billion for the quarter, compared to $2.14 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 42.2 percent.
